Search

Your search keyword '"Lohse, Christine M."' showing total 29 results
Start Over Author "Lohse, Christine M." Journal cancer
29 results on '"Lohse, Christine M."'

15. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement

Author

Frank, Igor, Cheville, John C., Blute, Michael L., Lohse, Christine M., Karnes, R. Jeffrey, Weaver, Amy L., Sebo, Thomas J., Nehra, Ajay, and Zincke, Horst

Subjects
Chemotherapy -- Research, Chemotherapy -- Influence, Cystectomy -- Research, Cystectomy -- Influence, Bladder cancer -- Prognosis, Bladder cancer -- Care and treatment, Cancer -- Chemotherapy, Cancer -- Research, Cancer -- Influence, Health
Published
2004

17. Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy

Author

Frank, Igor, Cheville, John C., Blute, Michael L., Lohse, Christine M., Nehra, Ajay, Weaver, Amy L., Karnes, R. Jeffrey, and Zincke, Horst

Subjects
Oncology, Experimental -- Analysis, Cancer patients -- Health aspects, Cancer patients -- Care and treatment, Bladder cancer -- Health aspects, Bladder cancer -- Care and treatment, Lymph nodes -- Health aspects, Lymph nodes -- Care and treatment, Cancer cells -- Genetic aspects, Cystectomy -- Methods, Cystectomy -- Usage, Cancer -- Health aspects, Cancer -- Care and treatment, Health
Published
2003

18. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials

Author

Leibovich, Bradley C., Blute, Michael L., Cheville, John C., Lohse, Christine M., Frank, Igor, Kwon, Eugene D., Weaver, Amy L., Parker, Alexander S., and Zincke, Horst

Subjects
Nephrectomy -- Physiological aspects, Nephrectomy -- Evaluation, Carcinoma, Renal cell -- Care and treatment, Carcinoma, Renal cell -- Prognosis, Carcinoma, Renal cell -- Patient outcomes, Cancer patients -- Prognosis, Health
Published
2003

20. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and core positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases

Author

Sebo, Thomas J., Cheville, John C., Riehle, Darren L., Lohse, Christine M., Pankratz, V. Shane, Myers, Robert P., Blute, Michael L., and Zincke, Horst

Subjects
Prostate cancer -- Prognosis, Ploidy -- Analysis, Biopsy, Needle, Tumor staging, Health
Published
2001

24. Oncofetal protein IMP3

Author

Jiang, Zhong, primary, Lohse, Christine M., additional, Chu, Peigou G., additional, Wu, Chin-Lee, additional, Woda, Bruce A., additional, Rock, Kenneth L., additional, and Kwon, Eugene D., additional

Published
2008
Full Text
View/download PDF

26. Metastatic prostate carcinoma to bone

Author

Cheville, John C., primary, Tindall, Donald, additional, Boelter, Christopher, additional, Jenkins, Robert, additional, Lohse, Christine M., additional, Pankratz, V. Shane, additional, Sebo, Thomas J., additional, Davis, Brian, additional, and Blute, Michael L., additional

Published
2002
Full Text
View/download PDF

27. Inverted urothelial papilloma

Author

Cheville, John C., primary, Wu, Kevin, additional, Sebo, Thomas J., additional, Cheng, Liang, additional, Riehle, Darren, additional, Lohse, Christine M., additional, and Pankratz, V. Shane, additional

Published
2000
Full Text
View/download PDF

28. ?Malignancy? in meningiomas

Author

Perry, Arie, primary, Scheithauer, Bernd W., additional, Stafford, Scott L., additional, Lohse, Christine M., additional, and Wollan, Peter C., additional

Published
1999
Full Text
View/download PDF

29. “Malignancy” in meningiomas

Author

Perry, Arie, Scheithauer, Bernd W., Stafford, Scott L., Lohse, Christine M., and Wollan, Peter C.

Abstract

Due to the rarity of malignancy in meningiomas, prior studies have been limited to small series. Controversies regarding the definition of malignant meningioma have complicated matters further. Although histologic anaplasia and extracranial metastasis are established criteria, the former is difficult to define and the latter represents a clinical finding. Traditionally, brain invasion has also been accepted, although this has recently been debated. In a prior series, the authors were unable to prove that 23 meningiomas that had invaded the brain were more aggressive than atypical meningiomas. The authors expanded their analysis to include 116 patients diagnosed with “malignant meningioma” due to brain invasion, frank anaplasia (20 mitoses per 10 high-power fields or histology resembling carcinoma, sarcoma, or melanoma), and/or extracranial metastasis. Patients were followed until death or for a median of 3.7 years. Survival time was highly variable, ranging from 10 days to 24 years. In multivariate analysis, histologic anaplasia (P = 0.0035), subtotal resection (P = 0.0038), 20 mitoses per 10 high-power fields (P = 0.0071), and nuclear atypia (P = 0.0068) were associated with poor survival. Of the 89 cases of meningioma that had invaded the brain, 23% were otherwise benign, 61% were otherwise atypical, and 17% were frankly anaplastic. Those without anaplasia behaved similarly to atypical meningiomas from the authors' prior study. In contrast, anaplastic meningiomas were usually fatal, associated with a median survival of 1.5 years. Based on these findings, the authors suggest that brain invasion constitutes an additional criterion for the diagnosis of atypical meningioma (World Health Organization [WHO] Grade II), whereas frank anaplasia indicates high grade (WHO Grade III–IV) malignancy. Cancer 1999;85:2046–56. © 1999 American Cancer Society.

Published
1999
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results